CBIZ take-private LBO — $55.00/share offer, $5.0bn enterprise value, 17.3% sponsor-net IRR, 1.91x MOIC

The $5 Billion CBIZ Take-Private: A Full LBO Reconstruction

A seven-exhibit LBO reconstruction of the announced Grant Thornton / New Mountain take-private of CBIZ (NYSE: CBZ) at $55.00/share, $5.0bn enterprise value. Base case: 1.91x MOIC, 17.3% sponsor-net IRR over a 4.05-year hold — three-quarters of it from EBITDA growth, 40% from deleveraging, next to nothing from multiple expansion. A three-case toggle also runs a Downside (10.4% IRR) and a Stress case where the deal loses money (0.84x MOIC). The Benefits & Insurance carve-out that’s part of the real deal isn’t in the model at all, and that gap — which the 10-K’s segment data suggests understates rather than overstates the problem — is the most interesting thing about it.

August 1, 2026 · Yirviel Somé
Indicateurs clés Akdital — valeur intrinsèque DCF 1 851,62 MAD, upside implicite +58,3%

Akdital S.A. — Modèle à trois états financiers & Valorisation DCF

Modèle à trois états financiers entièrement lié et valorisation DCF d’Akdital S.A., premier groupe de santé privée coté au Maroc — avec un audit documenté qui a corrigé les hypothèses de capex, la structure du WACC et l’horizon de valeur terminale.

July 14, 2026 · Yirviel Somé
GitHub LinkedIn Email